The most advanced malaria vaccine Mosquirix (GlaxoSmithKline) contains RTS,S antigen that is composed of (NANP)19 and the C-terminal domain of CSP fused to a Hepatitis B particle7, formulated with AS01 adjuvant. Here, DNAJC5 is linked to malaria.